400-921-8278
| Catalog_no | ADMC0616 |
| Product_name | Evofosfamide(TH-302) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 3120.00/8660.00/13560.00 |
| Specificity | TargetTargeting hypoxic regions of solid tumors with IC50 of 19 nM, demonstrates 270-fold enhanced cytotoxicity under hypoxia versus their potency under aerobic conditions, stable to cytochrome P450 metabolism. |
| Dilution | Hypoxia-activated prodrug[1] |
| Purification | >98% |
| Concentration | 靶点：See reference;IC50：Hypoxia-activated prodrug[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | TH 302; TH302 |
| Observed_band | 449.04 |
| Notes | TH-302 is selective hypoxia-activated prodrug targeting hypoxic regions of solid tumors with IC50 of 19 nM, demonstrates 270-fold enhanced cytotoxicity under hypoxia versus their potency under aerobic conditions, stable to cytochrome P450 metabolism. |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
